Fines Shaw
Psychiatric/Mental Health · Beaumont, CANPI 1467095224
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $8,246 of the $12,653 with a category attached, or 65.2%. 20 manufacturers reported payments, led by E.r. Squibb & Sons, L.L.C. at 40.0% of the total. 2025 is the largest year on record at $8,840, 6.5 times the $1,355 reported in 2023. Among psychiatric/mental health clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 365 payments — averaging $34.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- E.r. Squibb & Sons, L.L.C.$5K
- Neurocrine Biosciences, Inc.$2K
- Teva Pharmaceuticals USA, Inc.$1K
- Johnson & Johnson$916
- AbbVie$773
- Alkermes, Inc.$637
- plus $3K from 14 others
What the payments were for
- Consulting fees$3,30026%
- Travel & lodging$7896%
- Food & beverage$8,24665%
- Education$3193%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| E.r. Squibb & Sons, L.L.C. | 23 | $5,066 |
| Neurocrine Biosciences, Inc. | 69 | $1,644 |
| Teva Pharmaceuticals USA, Inc. | 47 | $1,082 |
| Johnson & Johnson | 41 | $916 |
| AbbVie | 36 | $773 |
| Alkermes, Inc. | 26 | $637 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 23 | $454 |
| Axsome Therapeutics, Inc. | 27 | $435 |
| Otsuka America Pharmaceutical, Inc. | 11 | $397 |
| Corium, LLC | 23 | $356 |
| Ironshore Pharmaceuticals Inc. | 9 | $176 |
| Lundbeck LLC | 6 | $163 |
| Collegium Pharmaceutical, Inc. | 6 | $162 |
| Vanda Pharmaceuticals Inc. | 5 | $132 |
| Tris Pharma Inc | 4 | $68 |
| Indivior Inc. | 3 | $66 |
| Bausch Health US, LLC | 3 | $61 |
| Vertical Pharmaceuticals, LLC | 1 | $25 |
| Noven Therapeutics, LLC | 1 | $21 |
| Almatica Pharma LLC | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$12,653 in reported general payments places this provider in the 95th percentile of 2,433 psychiatric/mental health providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| IngrezzaValbenazine Tosylate | 21 | $157,902 |
| Invega SustennaPaliperidone Palmitate | 12 | $39,324 |
| VraylarCariprazine Hcl | 12 | $16,968 |
| Oxcarbazepine | 24 | $1,655 |
| Olanzapine | 152 | $1,598 |
| Divalproex Sodium ErDivalproex Sodium | 50 | $1,403 |
| Desmopressin Acetate | 23 | $1,119 |
| Quetiapine Fumarate ErQuetiapine Fumarate | 36 | $783 |
| Divalproex Sodium | 43 | $743 |
| Aripiprazole | 84 | $733 |
| Quetiapine Fumarate | 72 | $619 |
| Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine | 13 | $547 |
| Lamotrigine | 32 | $517 |
| Risperidone | 75 | $477 |
| Clonazepam | 82 | $449 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Neurocrine Biosciences, Inc.Ingrezza | $1,644 | $157,90221 claims |
| Johnson & JohnsonInvega Sustenna | $916 | $39,32412 claims |
| AbbVieVraylar | $773 | $16,96812 claims |
| Almatica Pharma LLCSertraline Hcl | $18 | $29966 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,433 psychiatric/mental health providers in California.
Other psychiatric/mental health in Beaumont
- Carey MartinMillbrae$745K
- Liberty MaciasRedlands$288K
- Joshua BurgettSacramento$239K
- Jovita Ezirim-SalamialofojeLos Angeles$162K
- Angie-Kolleen TanThousand Oaks$159K
- Thy LamVista$121K
- Samantha PerkinsAnaheim$49K
- Yvette ElpidioOrange$43K
- Sarah KoLos Angeles$34K
- Jonathan LlamasPasadena$31K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.